DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Eisen T, Loembé AB, Shparyk Y. et al.
A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results.
Br J Cancer 2015;
113: 1140-1147
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.